H Osada Selected Research

H Osada Research Topics

Disease

10	Neoplasms (Cancer) 01/2021 - 09/2000
10	Lung Neoplasms (Lung Cancer) 09/2009 - 05/2000
4	Neoplasm Metastasis (Metastasis) 07/2007 - 10/2000
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2009 - 01/2001
2	Carcinogenesis 12/2012 - 11/2001
2	Leukemia 07/2000 - 03/2000
1	Eosinophilia 01/2020
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2015
1	Malignant Mesothelioma 01/2015
1	Bone Resorption 08/2012
1	Osteoporosis 08/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2008
1	Primary Hyperparathyroidism 04/2008
1	Glossopharyngeal Nerve Diseases (Glossopharyngeal Neuralgia) 12/2007
1	Syncope (Fainting) 12/2007
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2007
1	Birth Weight (Birth Weights) 03/2007
1	Dyspnea (Shortness of Breath) 01/2007
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2007
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2007
1	Dermatomyositis (Dermatopolymyositis) 01/2007
1	Adenocarcinoma of Lung 11/2005
1	Hypersensitivity (Allergy) 12/2001
1	Contact Dermatitis (Eczema, Contact) 12/2001
1	Hypoxia (Hypoxemia) 12/2001
1	Anaphylaxis (Anaphylactic Shock) 12/2001
1	Pulmonary Hypertension 12/2001
1	Inflammation (Inflammations) 07/2001
1	Colonic Neoplasms (Colon Cancer) 03/2001
1	Glioma (Gliomas) 02/2001
1	Necrosis 12/2000
1	Colorectal Neoplasms (Colorectal Cancer) 10/2000
1	Lafora Disease 09/2000
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 09/2000
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2000
1	Fallopian Tube Diseases 05/2000

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2015 - 03/2000
3	Phosphotransferases (Kinase)IBA 01/2015 - 03/2000
3	Transforming Growth Factor beta (TGF-beta)IBA 11/2005 - 05/2000
2	Biological ProductsIBA 08/2014 - 05/2000
2	Interleukin-10 (Interleukin 10)IBA 05/2001 - 03/2001
2	AngiopoietinsIBA 05/2001 - 02/2001
2	Antineoplastic Agents (Antineoplastics)IBA 07/2000 - 03/2000
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020
1	AsbestosIBA 01/2015
1	Neurofibromin 2 (Merlin)IBA 12/2012
1	Tartrate-Resistant Acid PhosphataseIBA 08/2012
1	OsteoprotegerinIBA 08/2012
1	Alkaline PhosphataseIBA 08/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2009
1	TubulinIBA 01/2009
1	MicroRNAs (MicroRNA)IBA 09/2007
1	Antisense OligonucleotidesIBA 09/2007
1	Homeodomain Proteins (Proteins, Homeobox)IBA 07/2007
1	Semaphorins (Semaphorin)IBA 06/2007
1	Factor V (Coagulation Factor V)IBA 06/2007
1	methyl 4-azidophenylacetimidate (APAI)IBA 03/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2007
1	Oxygen (Dioxygen)IBA 01/2007
1	AntibodiesIBA 01/2007
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2001
1	Protein Tyrosine PhosphatasesIBA 12/2001
1	Picryl Chloride (Trinitrochlorobenzene)IBA 12/2001
1	Atrial Natriuretic Factor (ANF)IBA 12/2001
1	dinitrophenyl-bovine serum albuminIBA 12/2001
1	Immunoglobulin E (IgE)IBA 12/2001
1	theasinensin AIBA 11/2001
1	Histones (Histone)IBA 11/2001
1	Transforming Growth Factor-beta Type II ReceptorIBA 11/2001
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2001
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 11/2001
1	lucilactaeneIBA 10/2001
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2001
1	CytokinesIBA 03/2001
1	ThrombospondinsIBA 03/2001
1	Angiopoietin-2IBA 02/2001
1	Angiopoietin-1IBA 02/2001
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2001
1	MitogensIBA 12/2000
1	LigandsIBA 12/2000
1	degradable starch microspheresIBA 10/2000
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 10/2000
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2000
1	Dual-Specificity PhosphatasesIBA 09/2000
1	Protein Isoforms (Isoforms)IBA 09/2000
1	CamptothecinIBA 03/2000
1	Myelin Basic ProteinIBA 03/2000
1	Fluorouracil (Carac)FDA LinkGeneric 03/2000
1	Protein Kinases (Protein Kinase)IBA 03/2000
1	cytotrienin AIBA 03/2000
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2000

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2021 - 01/2009
3	Therapeutics 06/2007 - 10/2000
1	Radiotherapy 01/2021
1	Aftercare (After-Treatment) 01/2020
1	Oral Administration 08/2014
1	Renal Dialysis (Hemodialysis) 04/2008
1	Microvascular Decompression Surgery 12/2007
1	Thoracotomy 06/2000
1	General Anesthesia 05/2000